Trial Profile
Registrational trial of buprenorphine/naloxone for opioid-addiction treatment
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 16 Feb 2011
Price :
$35
*
At a glance
- Drugs Buprenorphine/naloxone (Primary)
- Indications Opioid-related disorders
- Focus Adverse reactions; Registrational; Therapeutic Use
- 16 Feb 2011 Planned End Date changed to 1 Dec 2011.
- 16 Feb 2011 New trial record